Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chitosan-coated silver nanoparticles amplify glycopeptide efficacy against <i>Staphylococcus aureus</i>.

Frontiers in microbiology·2026
Same author

Tumor Lipidomic Changes after Treatment with Polymeric Hydroxychloroquine in a Syngeneic Murine Model of Pancreatic Cancer.

ACS omega·2026
Same author

Structure-Activity Mapping of Intraperitoneal mRNA-LNPs: Decoupling Tumor and Liver Biodistribution in Pancreatic Cancer.

bioRxiv : the preprint server for biology·2026
Same author

PAMD-Ch17, a Polymeric Analog of Plerixafor, Induces Mitochondrial Dysfunction in T-ALL Cells Independent of CXCR4.

Molecular cancer therapeutics·2026
Same author

Inhalable perfluorocarbon RNA nanocapsules overcome biological barriers to treat lung metastases.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Challenges and opportunities in nanotherapeutics targeted for central nervous system disorders.

Nanoscale·2025

Related Experiment Video

Updated: Jun 22, 2026

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
10:58

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries

Published on: September 6, 2012

DNA release dynamics from bioreducible poly(amido amine) polyplexes.

Lei Wan1, Yezi You, Yi Zou

  • 1Department of Chemical Engineering and Materials Science, Wayne State University, Detroit, Michigan 48202, USA.

The Journal of Physical Chemistry. B
|June 16, 2009
PubMed
Summary
This summary is machine-generated.

Bioreducible poly(amido amine) polyplexes show controlled DNA release via depolymerization. Atomic force microscopy revealed distinct disassembly stages, confirming their potential as DNA delivery vectors.

More Related Videos

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
08:30

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
08:09

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

Related Experiment Videos

Last Updated: Jun 22, 2026

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
10:58

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries

Published on: September 6, 2012

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
08:30

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
08:09

Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery

Published on: August 6, 2019

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Nanotechnology

Background:

  • Bioreducible poly(amido amine)s are promising for DNA delivery.
  • Understanding DNA release mechanisms is crucial for effective gene therapy vectors.
  • Polyplex disassembly dynamics require detailed investigation.

Purpose of the Study:

  • To investigate the real-time DNA release dynamics of bioreducible poly(amido amine) polyplexes.
  • To elucidate the stages and mechanisms of polyplex disassembly.
  • To assess the influence of polymer properties on DNA release.

Main Methods:

  • Real-time atomic force microscopy (AFM) was employed.
  • Experiments were conducted in a simulated physiological reducing environment using dithiothreitol.
  • Polyplexes with varying disulfide content, molecular weight, and architecture were analyzed.

Main Results:

  • Distinct stages of polyplex disassembly were observed, including toroid formation, aggregation/fusion, and DNA chain release.
  • DNA release rate was found to be dependent on the disulfide content of the polyplexes.
  • Intermediate structures exhibited high heterogeneity, and disassembly induced particle growth.

Conclusions:

  • Bioreducible poly(amido amine)s demonstrate potential as controlled DNA delivery vectors.
  • The study provides physical insights into DNA release pathways and intermediate structures.
  • Disassembly-induced colloidal and morphological instability is a critical factor for vector design.